AI-generated summary
The authors report a randomized study of 26 collegiate football players who received either active or sham transcranial photobiomodulation at 810 nm over one season. Diffusion MRI markers of neuroinflammation and axonal remodeling increased over the season in the sham group but were relatively stable in the active group, with some reductions. The authors describe this as suggestive of mitigation, but the study covers a single season.
- Participants
- 26
- Who or what was studied
- Collegiate American football players (NCAA Division I) exposed to repetitive head acceleration events, randomly assigned to active (n = 13) or sham (n = 13) photobiomodulation.
- Wavelengths
- 810 nm
- Limits stated in the abstract
- The authors state that the findings cover a single season, and the abstract does not report functional or clinical outcomes, so longer-term benefit and functional impact remain unestablished.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Transcranial photobiomodulation, Neuroinflammation, Sham, Traumatic brain injury, Brain injury, Wellness. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.